Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029517 · ClinicalTrials.gov registry record · NA
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
A NA study of Coronary Artery Disease and Diabetes Mellitus, sponsored by Roswell Park Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06029517 is a NA study of Coronary Artery Disease and Diabetes Mellitus that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 48 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06029517, a NA study of Coronary Artery Disease and Diabetes Mellitus, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men
Conditions Studied
Interventions
- OTHER Education Intervention
- OTHER Interview
- PROCEDURE Discussion
Study Locations (1)
New York
- Roswell Park Comprehensive Cancer Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2026-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06029517
The ClinicalTrials.gov registry entry for NCT06029517 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 3 interventions - of which Education Intervention is the first listed.
NCT06029517 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06029517 about?
NCT06029517 is a clinical study titled "A Sugar-Sweetened Beverage Reduction Intervention for Native American Men". This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may l...
What is the current status of trial NCT06029517?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2022-07-20. Estimated completion is 2026-09-15.
What conditions does trial NCT06029517 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Diabetes Mellitus, Obesity-Related Malignant Neoplasm, Cardiovascular Disorder.
What interventions are being tested in trial NCT06029517?
The interventions under investigation include: Education Intervention (OTHER), Interview (OTHER), Discussion (PROCEDURE).
Who is sponsoring clinical trial NCT06029517?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06029517 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.